1. HOLX will announce Q3 fiscal 2025 results on July 30. 2. A conference call will be held on the same day at 4:30 PM ET. 3. The results will impact investor sentiment and stock performance. 4. Hologic focuses on women's health through early detection and treatment.
Regular financial results announcements can lead to volatility but don’t guarantee direction. Historical performance shows mixed reactions around results, with some quarters positively impacting prices and others not.
The announcement of financial results is significant for investors making future predictions. Given Hologic's focus area, results can influence not just stock performance but broader market sentiment towards women's health technologies.
Immediate price reaction may occur post-announcement, but long-term depends on sustained performance. Similar announcements in the past have shown immediate reactions but not lasting impacts.
MARLBOROUGH, Mass.--(BUSINESS WIRE)--Hologic, Inc. (Nasdaq: HOLX) announced today that the Company plans to release its financial results for the third quarter of fiscal 2025 on Wednesday, July 30, after the market closes. In conjunction with the release, management will host a conference call that day at 4:30 p.m. Eastern Time.
Hologic to Announce Financial Results for the Third Quarter of Fiscal 2025 on Wednesday, July 30, 2025
Share
Interested participants may listen to the call by dialing (866) 400-0049 (in the United States and Canada) or +1 (313) 209-4906 (for international callers) and referencing access code 5212316. Participants may also click here to join. Participants should dial in 5-10 minutes before the call begins.
Hologic will provide a live and webcast replay of the call on the Company’s website at investors.hologic.com. The call will be available there for 30 days. The webcast replay will be available approximately two hours after the call ends.
About Hologic
Hologic, Inc. is an innovative medical technology company primarily focused on improving women's health and well-being through early detection and treatment. For more information on Hologic, visit www.hologic.com.
SOURCE: Hologic, Inc.